Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fake Products Hurting China (China)

This article was originally published in PharmAsia News

Executive Summary

China will not be able to convince the international community that Chinese corporate distribution of fraudulent and toxic medicine and food has ended because it tried and executed its former drug safety agency head. Recent scandals have eroded global confidence in the "Made in China" label. China will have to take more serious widespread actions to enforce product safety laws and regain its former global reputation. Today the World Health Organization hypothesizes that 25 percent of medicine consumed in developing countries may be counterfeit. China's solution to this problem is a key part of the global fake drug puzzle. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066339

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel